OTCMKTS:MMNFFMedmen Enterprises Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Medmen Enterprises Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.24 +0.01 (+4.35 %) (As of 07/6/2020 04:00 PM ET) Add Compare Share Today's Range$0.22Now: $0.24▼$0.2550-Day Range$0.20MA: $0.25▼$0.3752-Week Range$0.09Now: $0.24▼$2.61Volume708,678 shsAverage Volume2.47 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsHeadlinesSocial Media MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis company in the United States. The company cultivates, produces, and distributes, and retails recreational and medicinal cannabis. As of November 1, 2018, it had licenses for 69 retail stores; and 17 cultivation and production facilities across 12 states. The company is headquartered in Culver City, California.Read More Beat the Market (BTM) Rank™ 3.0 Analyst's Opinion Consensus RatingMedmen Enterprises has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 2 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $2.38, Medmen Enterprises has a potential upside of 889.6% from its current price of $0.24.Amount of Analyst CoverageMedmen Enterprises has only been the subject of 1 research reports in the past 90 days. Previous Next 3.8 Community Rank Outperform VotesMedmen Enterprises has received 124 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMedmen Enterprises has received 40 “underperform” votes. (Add your “underperform” vote.)Community SentimentMedmen Enterprises has received 75.61% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Medmen Enterprises and other stocks. Vote “Outperform” if you believe MMNFF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MMNFF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldMedmen Enterprises does not currently pay a dividend.Dividend GrowthMedmen Enterprises does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Medmen Enterprises insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.0Community Rank: 3.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.36 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:MMNFF Previous Symbol CUSIPN/A CIKN/A Webwww.medmen.com Phone855-292-8399Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees1,000 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable OTC:MMNFF Rates by TradingView Receive MMNFF News and Ratings via Email Sign-up to receive the latest news and ratings for MMNFF and its competitors with MarketBeat's FREE daily newsletter. Medmen Enterprises (OTCMKTS:MMNFF) Frequently Asked Questions How has Medmen Enterprises' stock been impacted by COVID-19 (Coronavirus)? Medmen Enterprises' stock was trading at $0.1539 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MMNFF shares have increased by 55.9% and is now trading at $0.24. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Medmen Enterprises? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medmen Enterprises in the last year. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Medmen Enterprises. What price target have analysts set for MMNFF? 4 equities research analysts have issued 1 year price objectives for Medmen Enterprises' stock. Their forecasts range from $0.75 to $4.00. On average, they anticipate Medmen Enterprises' share price to reach $2.38 in the next year. This suggests a possible upside of 889.6% from the stock's current price. View analysts' price targets for Medmen Enterprises. Has Medmen Enterprises been receiving favorable news coverage? Media headlines about MMNFF stock have been trending negative recently, InfoTrie reports. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Medmen Enterprises earned a news impact score of -2.1 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about Medmen Enterprises. Who are some of Medmen Enterprises' key competitors? Some companies that are related to Medmen Enterprises include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF), Cipher Pharmaceuticals (CPHRF) and CLS Holdings USA (CLSH). View all competitors. Who are Medmen Enterprises' key executives? Medmen Enterprises' management team includes the following people: Mr. Adam Bierman, Co-Founder, CEO & Director (Age 38)Mr. Andrew Modlin, Co-Founder, Pres & Director (Age 32)Mr. Michael W. Kramer, Chief Financial Officer (Age 55)Mr. James Miller, VP of Accounting (Age 59)Mr. Ryan Lissack, Chief Technology Officer What is Medmen Enterprises' stock symbol? Medmen Enterprises trades on the OTCMKTS under the ticker symbol "MMNFF." How do I buy shares of Medmen Enterprises? Shares of MMNFF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Medmen Enterprises' stock price today? One share of MMNFF stock can currently be purchased for approximately $0.24. What is Medmen Enterprises' official website? The official website for Medmen Enterprises is www.medmen.com. How can I contact Medmen Enterprises? The company can be reached via phone at 855-292-8399. This page was last updated on 7/7/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
